相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atypical APC/C-dependent degradation of Mcl-1 provides an apoptotic timer during mitotic arrest
Lindsey A. Allan et al.
EMBO JOURNAL (2018)
Epigenetics in ovarian cancer: premise, properties, and perspectives
Qilian Yang et al.
MOLECULAR CANCER (2018)
Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer
Anna Fagotti et al.
LANCET ONCOLOGY (2018)
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
George Au-Yeung et al.
CLINICAL CANCER RESEARCH (2017)
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1
Norihiro Ishii et al.
ONCOTARGET (2017)
Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Xiaojia Niu et al.
CLINICAL CANCER RESEARCH (2016)
Shipping Drug Resistance: Extracellular Vesicles in Ovarian Cancer
Elke Pogge von Strandmann et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Mcl-1 dynamics influence mitotic slippage and death in mitosis
Olivia Sloss et al.
ONCOTARGET (2016)
Quantification of apoptosis and necroptosis at the single cell level by a combination of Imaging Flow Cytometry with classical Annexin V/propidium iodide staining
Sabine Pietkiewicz et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
Yu Xiao et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest
Manuel D. Haschka et al.
NATURE COMMUNICATIONS (2015)
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Nirmala Chandralega Kampan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver
MOLECULAR BIOLOGY OF THE CELL (2014)
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Lauren M. Zasadil et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
APC/C is an essential regulator of centrosome clustering
Konstantinos Drosopoulos et al.
NATURE COMMUNICATIONS (2014)
Programming cancer cells for high expression levels of Mcl1
Franziska Ertel et al.
EMBO REPORTS (2013)
Cohesion Fatigue Explains Why Pharmacological Inhibition of the APC/C Induces a Spindle Checkpoint-Dependent Mitotic Arrest
Pablo Lara-Gonzalez et al.
PLOS ONE (2012)
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Jaeyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Spindle Poisons and Cell Fate: A Tale of Two Pathways
Daniel R. Matson et al.
MOLECULAR INTERVENTIONS (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest
Margaret E. Harley et al.
EMBO JOURNAL (2010)
Sister chromatid tension and the spindle assembly checkpoint
Luigi Nezi et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
Aniek Janssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5
Jue Shi et al.
CANCER RESEARCH (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Amplicon profiles in ovarian serous carcinomas
Kentaro Nakayama et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The anaphase promoting complex/cyclosome: a machine designed to destroy
Jan-Michael Peters
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death
BAA Weaver et al.
CANCER CELL (2005)
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage
WK Tao et al.
CANCER CELL (2005)
Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint
CL Rieder et al.
DEVELOPMENTAL CELL (2004)
The dynamic kinetochore-microtubule interface
H Maiato et al.
JOURNAL OF CELL SCIENCE (2004)
MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis
RW Craig
LEUKEMIA (2002)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
分享论文
